InvestorsHub Logo

circuitcity

03/31/20 10:05 PM

#259350 RE: raistthemage #259346

Raist, I am thinking hard on your idea, what do we gain by doing this beside shut out reddy and Hikma? So basically amrn is in bed with Teva, another generic, like partners, right? No offense, trying to see the merits here.

ilovetech

03/31/20 10:26 PM

#259367 RE: raistthemage #259346

Rais, there's nothing left to rationalize. She's wrong. Reversal will come. The wait blows. The U.S. didn't except Jelis. Where's obviousness? Consequently, $500 million Reduce-it required. Where's obviousness? China won't except Reduce-it in a 8,000 multinational study? It has to be run with Chinese only. Where's obviousness!

I'll tell you what's obviousness, Du's incompetence!

ILT